Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.

Mucosal immunity likely plays an important role in the defense against Streptococcus pneumoniae. This study examined whether pneumococcal carriage and acute otitis media induce mucosal antibodies to pneumococcal capsular polysaccharides (Pnc-PSs) of types 1, 6B, 11A, 14, 19F, and 23F. Immunoglobulin (Ig) A, IgG, and secretory (S) Ig anti-Pnc-PS antibodies were measured by enzyme immunoassay in the saliva of children at ages 6, 12, 18, and 24 months and were analyzed in relation to the previous pneumococcal findings. A larger proportion of IgA-positive samples and higher concentrations of type-specific IgA antibodies were detected in samples of children with pneumococci of the given types cultured before sampling from nasopharyngeal samples or middle-ear fluid, compared with children who had cultures negative for pneumococci of the indicated types or of all types. The IgA and S-Ig concentrations correlated strongly, which suggests that the anti-Pnc-PS IgA was secretory. Salivary anti-Pnc-PS IgG was detected only rarely.

[1]  H. Käyhty,et al.  Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young Children , 2002, Clinical and Vaccine Immunology.

[2]  P. Mäkelä,et al.  Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media , 2002, The Pediatric infectious disease journal.

[3]  J. Eskola,et al.  Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. , 2001, Vaccine.

[4]  J. Eskola,et al.  Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. , 2001, The Journal of infectious diseases.

[5]  H. Pursiainen,et al.  Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. , 2001, The Journal of infectious diseases.

[6]  A. Takala,et al.  Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. , 2001, The Journal of infectious diseases.

[7]  A. Takala,et al.  Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life , 2001, The Pediatric infectious disease journal.

[8]  B. Simell,et al.  Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. , 2001, The Journal of infectious diseases.

[9]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[10]  J. Eskola,et al.  Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine , 2001, The Pediatric infectious disease journal.

[11]  B. Greenwood,et al.  Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children. , 2000, Vaccine.

[12]  G. Carlone,et al.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. , 2000, The Journal of infectious diseases.

[13]  H. Käyhty,et al.  Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific? , 2000, Clinical Diagnostic Laboratory Immunology.

[14]  E. Swiatlo,et al.  Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage of Streptococcus pneumoniae , 2000, Infection and Immunity.

[15]  J. Eskola,et al.  Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. , 2000, Vaccine.

[16]  K. Edwards,et al.  Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. , 1999, The Journal of infectious diseases.

[17]  R. Huebner,et al.  Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.

[18]  I. Jónsdóttir,et al.  Intranasal Immunization with Pneumococcal Polysaccharide Conjugate Vaccines Protects Mice against Invasive Pneumococcal Infections , 1999, Infection and Immunity.

[19]  C. Frasch,et al.  Pneumococcal Capsular Polysaccharide Preparations May Contain Non-C-Polysaccharide Contaminants That Are Immunogenic , 1999, Clinical Diagnostic Laboratory Immunology.

[20]  I. Kwon,et al.  Protective Immunity of Microsphere-Based Mucosal Vaccines against Lethal Intranasal Challenge withStreptococcus pneumoniae , 1999, Infection and Immunity.

[21]  D. L. Klein,et al.  Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. , 1998, Vaccine.

[22]  R. Malley,et al.  Anticapsular polysaccharide antibodies and nasopharyngeal colonization with Streptococcus pneumoniae in infant rats. , 1998, The Journal of infectious diseases.

[23]  S. Obaro,et al.  Carriage of pneumococci after pneumococcal vaccination , 1996, The Lancet.

[24]  J. Mcghee,et al.  Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization. , 1996, Vaccine.

[25]  C. Liebeler,et al.  Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. , 1996, The Journal of infectious diseases.

[26]  J. Eskola,et al.  Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. , 1995, The Journal of infectious diseases.

[27]  S. Quataert,et al.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.

[28]  M. Leinonen,et al.  First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants , 1986, Pediatric infectious disease.

[29]  M. Heidelberger Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antisera. , 1984, Molecular immunology.

[30]  C. S. Lin,et al.  Capsular polysaccharides of nongroupable streptococci that cross-react with pneumococcal group 19. , 1984, Journal of immunology.

[31]  P. Mäkelä,et al.  Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. , 1984, Pediatrics.

[32]  M. Pichichero,et al.  Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. , 1983, The Journal of allergy and clinical immunology.

[33]  R. Douglas,et al.  Antibody response to pneumococcal vaccination in children younger than five years of age. , 1983, The Journal of infectious diseases.

[34]  A. Husband,et al.  Ontogeny of the secretory immune system in man. , 1982, Australian and New Zealand journal of medicine.

[35]  G. W. Zoller Pneumococcal vaccine and otitis media , 1981 .

[36]  C. Lee,et al.  Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides. , 1981, Journal of immunology.

[37]  M. Pichichero,et al.  A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. , 1981, The Journal of clinical investigation.

[38]  A. Plebani,et al.  Ontogeny of Secretory Immunity: Levels of Secretory IgA and Natural Antibodies in Saliva , 1980, Pediatric Research.

[39]  M. Leinonen,et al.  PNEUMOCOCCAL VACCINE AND OTITIS MEDIA , 1980, The Lancet.

[40]  P. Mäkelä,et al.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. , 1977, Pediatrics.

[41]  J. C. Parke,et al.  Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976). , 1977, The Journal of infectious diseases.

[42]  M. Heidelberger,et al.  Immunochemical relationships between bacteria belonging to two separate families: pneumococci and Klebsiella. , 1976, Immunochemistry.

[43]  J. C. Parke,et al.  Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. , 1975, The Journal of allergy and clinical immunology.

[44]  O. Westphal,et al.  Relations between structures of three K polysaccharides of Escherichia coli and cross-reactivity in antipneumococcal sera , 1968, Journal of bacteriology.